These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 24008552

  • 1. A novel colon cancer gene therapy using rAAV‑mediated expression of human shRNA-FHL2.
    Wu Y, Guo Z, Zhang D, Zhang W, Yan Q, Shi X, Zhang M, Zhao Y, Zhang Y, Jiang B, Cheng T, Bai Y, Wang J.
    Int J Oncol; 2013 Nov; 43(5):1618-26. PubMed ID: 24008552
    [Abstract] [Full Text] [Related]

  • 2. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis.
    Wang J, Yang Y, Xia HH, Gu Q, Lin MC, Jiang B, Peng Y, Li G, An X, Zhang Y, Zhuang Z, Zhang Z, Kung HF, Wong BC.
    Gastroenterology; 2007 Mar; 132(3):1066-76. PubMed ID: 17383428
    [Abstract] [Full Text] [Related]

  • 3. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X, Jiao X, Jiao J, Zhang T, Cui B.
    Gene; 2018 Aug 30; 669():99-106. PubMed ID: 29800735
    [Abstract] [Full Text] [Related]

  • 4. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
    Hua G, He C, Lv X, Fan L, Wang C, Remmenga SW, Rodabaugh KJ, Yang L, Lele SM, Yang P, Karpf AR, Davis JS, Wang C.
    Cell Death Dis; 2016 Jul 14; 7(7):e2297. PubMed ID: 27415427
    [Abstract] [Full Text] [Related]

  • 5. Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer.
    Xue Z, Sun PH, Zhu LM, Jiang SH, Qiao MM, Chi AL, Tu SP.
    Oncol Rep; 2011 Apr 14; 25(4):1039-46. PubMed ID: 21279308
    [Abstract] [Full Text] [Related]

  • 6. ShRNA-mediated gene silencing of heat shock protein 70 inhibits human colon cancer growth.
    Zhong MA, Zhang H, Qi XY, Lu AG, You TG, Gao W, Guo XL, Zhou ZQ, Yang Y, Wang CJ.
    Mol Med Rep; 2011 Apr 14; 4(5):805-10. PubMed ID: 21725599
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
    Ebrahimian T, Arfa O, Simeone S, Lemarié CA, Lehoux S, Wassmann S.
    Circ Res; 2014 Jan 03; 114(1):114-23. PubMed ID: 24084691
    [Abstract] [Full Text] [Related]

  • 8. FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29.
    Amann T, Egle Y, Bosserhoff AK, Hellerbrand C.
    Oncol Rep; 2010 Jun 03; 23(6):1669-74. PubMed ID: 20428824
    [Abstract] [Full Text] [Related]

  • 9. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.
    Cancer Gene Ther; 2002 May 03; 9(5):453-63. PubMed ID: 11961668
    [Abstract] [Full Text] [Related]

  • 10. The four and a half LIM-only protein 2 regulates liver homeostasis and contributes to carcinogenesis.
    Nouët Y, Dahan J, Labalette C, Levillayer F, Julien B, Jouvion G, Cairo S, Vives FL, Ribeiro A, Huerre M, Colnot S, Perret C, Nhieu JT, Tordjmann T, Buendia MA, Wei Y.
    J Hepatol; 2012 Nov 03; 57(5):1029-36. PubMed ID: 22796152
    [Abstract] [Full Text] [Related]

  • 11. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
    Wang Q, Wang X, Tian X, Tang R, Xu X.
    J Mol Histol; 2016 Apr 03; 47(2):105-16. PubMed ID: 26759260
    [Abstract] [Full Text] [Related]

  • 12. The four-and-a-half-LIM protein 2 (FHL2) is overexpressed in gliomas and associated with oncogenic activities.
    Li M, Wang J, Ng SS, Chan CY, Chen AC, Xia HP, Yew DT, Wong BC, Chen Z, Kung HF, Lin MC.
    Glia; 2008 Sep 03; 56(12):1328-38. PubMed ID: 18615633
    [Abstract] [Full Text] [Related]

  • 13. Growth inhibition and apoptosis of human B-cell lymphoma in vitro and in vivo by Bcl-2 short hairpin RNA.
    Liu Y, Shen Y, Qin C, Shi Y, Rong G, Yu X.
    Oncol Rep; 2013 Jan 03; 29(1):244-52. PubMed ID: 23076380
    [Abstract] [Full Text] [Related]

  • 14. FHL2 silencing reduces Wnt signaling and osteosarcoma tumorigenesis in vitro and in vivo.
    Brun J, Dieudonné FX, Marty C, Müller J, Schüle R, Patiño-García A, Lecanda F, Fromigué O, Marie PJ.
    PLoS One; 2013 Jan 03; 8(1):e55034. PubMed ID: 23383046
    [Abstract] [Full Text] [Related]

  • 15. FHL2 inhibits the Id3-promoted proliferation and invasive growth of human MCF-7 breast cancer cells.
    Chen YH, Wu ZQ, Zhao YL, Si YL, Guo MZ, Han WD.
    Chin Med J (Engl); 2012 Jul 03; 125(13):2329-33. PubMed ID: 22882857
    [Abstract] [Full Text] [Related]

  • 16. miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer.
    Huang Z, Li Q, Luo K, Zhang Q, Geng J, Zhou X, Xu Y, Qian M, Zhang JA, Ji L, Wu J.
    Cell Death Dis; 2019 May 08; 10(5):372. PubMed ID: 31068580
    [Abstract] [Full Text] [Related]

  • 17. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
    Li X, Liu X, Li CY, Ding Y, Chau D, Li G, Kung HF, Lin MC, Peng Y.
    Int J Oncol; 2006 Sep 08; 29(3):595-603. PubMed ID: 16865275
    [Abstract] [Full Text] [Related]

  • 18. [Construction and activity of recombinant adeno-associated virus expressing vasostatin].
    Diao Y, Ma J, Li X, Sun X, Xu R.
    Sheng Wu Gong Cheng Xue Bao; 2008 Nov 08; 24(11):1949-54. PubMed ID: 19256344
    [Abstract] [Full Text] [Related]

  • 19. [Biological behaviour of colon cancer cells transfected with C-erbB2 shRNA plasmid].
    Zhao DL, Dang CX, Sui YX.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Apr 08; 28(4):371-3. PubMed ID: 22482406
    [Abstract] [Full Text] [Related]

  • 20. Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression.
    Tu SP, Sun YW, Cui JT, Zou B, Lin MC, Gu Q, Jiang SH, Kung HF, Korneluk RG, Wong BC.
    Cancer; 2010 Mar 01; 116(5):1252-63. PubMed ID: 20082449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.